Free Consultation 215.567.2010

Articles

U.S. Supreme Court Tackles Overseas Damages for US Patent Infringement

Posted on May 9, 2018 in Articles

The U.S. Supreme Court has rarely addressed the issue of patent damages, but a case currently before the […]

Read More

What to Do When the Patent Office Says ‘No’

Posted on Mar 28, 2018 in Articles

According to the U.S. Supreme Court, a patent application is one of the most difficult legal instruments that can be drafted. Small wonder that most patent applications are initially rejected by the Patent Office. Although negotiating with the Patent Office examiner, including presenting amendments and arguments often will lead to a patent application being issued as a U.S. patent, there are times when no amount of effort will translate into success.

Read More

Court Applies ‘Chevron’ Deference to Patent Law in ‘Fractured’ Decision

Posted on Feb 21, 2018 in Articles

It is unusual for the Federal Circuit to apply the doctrine of Chevron deference to patent law, but a recent decision is noteworthy—and fractured.

Read More

Several Steps to Improve Your Patent Strategy in 2018

Posted on Jan 25, 2018 in Articles

If the survival and growth of your business depends on the development of new technology, the beginning of the new year is a good time to think about your intellectual property (IP) protection and how it can be improved.

Read More

The Hottest Patent Law Issues of 2017

Posted on Jan 8, 2018 in Articles

As we start the new year, let’s look back at the most important patent law opinions of 2017.

Read More

Controversial Strategy: Selling Patents to a Native American Tribe

Posted on Dec 4, 2017 in Articles

Allergan (a pharmaceutical company) is the manufacturer of Restasis, a prescription eye drop that is used to treat Chronic Dry Eye disease by increasing tear production. Restasis has been a commercial success, with sales in 2016 of approximately $1.5 billion, and Allergan’s website states that its formulation has been “prescribed 6.4 million times since 2003.” Restasis is patented, and those patents received significant attention last month when they were sold to a Native American tribe—as a litigation strategy.

Read More

Don’t Let Your Trademark Become Generic

Posted on Oct 25, 2017 in Articles

A music video went viral this month, but it’s doubtful you know any of its musicians. The tune is quite catchy, and the performance is not only professional, but very enjoyable. What is the theme of the song? Coming of age? A broken heart? No. It’s a music video about Velcro Brand Fasteners and the VELCRO trademark.

Read More

Why Patent Claims Language Must Be Clearly Written

Posted on Sep 27, 2017 in Articles

Everyday business communication is hard enough. With all of the subtleties and nuances of language, the message received by an individual may not match what was intended. But with patent claims, the need for definiteness is far greater.

Read More

Patent Unenforceable Based on Inequitable Conduct

Posted on Aug 23, 2017 in Articles

It’s been called the atomic bomb of ­patent law—inequitable conduct. It happens when a patent is applied for, but the duty of candor, disclosure and good faith toward the U.S. Patent and Trademark Office (USPTO) is violated. If proven to have occurred during patent procurement, then the entire resulting patent becomes unenforceable.

Read More

Trademarks and the First Amendment Considered by Supreme Court

Posted on Jul 26, 2017 in Articles

When I studied constitutional law in law school, one subject was certainly never mentioned in that class: trademarks. After last month’s U.S. Supreme Court decision in Matal v. Tam, that may change.

Read More

Philadelphia

1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map

Delaware

King Street Plaza - Suite 304. 800 N. King Street
Wilmington, Delaware 19801

302-544-9100 | 302-544-9103

View Map

Lehigh Valley

2030 Tilghman Street, Suite 201A
Allentown, Pennsylvania 18104-4399

610-255-7551 | 610-255-7542

View Map